Key regions: China, Europe, Australia, United States, Germany
The Other Pharmaceuticals market in CIS has been developing steadily over the years with certain trends and developments that have shaped the market.
Customer preferences: Customers in the CIS region have shown a growing preference for generic drugs due to their lower prices and wider availability. This has led to an increase in demand for generic drugs in the Other Pharmaceuticals market. Additionally, customers have shown a preference for over-the-counter drugs which has also contributed to the growth of the market.
Trends in the market: One trend in the Other Pharmaceuticals market in CIS is the increasing investment in research and development by pharmaceutical companies. This has led to the development of new and innovative drugs that cater to the specific needs of the CIS market. Another trend is the rise in e-commerce platforms which has made it easier for customers to access drugs and has contributed to the growth of the market.
Local special circumstances: The Other Pharmaceuticals market in CIS is unique due to the varying regulations in different countries within the region. This has led to differences in the availability of certain drugs and the prices of drugs in different countries. Additionally, the market is also influenced by the political and economic climate of the region which can impact the demand for drugs.
Underlying macroeconomic factors: The growth of the Other Pharmaceuticals market in CIS is also influenced by macroeconomic factors such as population growth, increasing healthcare expenditure, and the prevalence of certain diseases. The aging population in the region has led to an increase in demand for drugs for chronic diseases such as cardiovascular diseases and diabetes. Additionally, the increasing healthcare expenditure in the region has led to an increase in the affordability of drugs which has contributed to the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
